⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ScieGen Pharmaceuticals, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ScieGen Pharmaceuticals, Inc.
↗Hauppauge, New York, USA
ScieGen Pharmaceuticals, Inc. is a dynamic generic pharmaceutical company based in Hauppauge, New York, founded in 2009. The company is dedicated to the development, manufacturing, marketing, and distribution of high-quality generic pharmaceutical products at affordable prices. It operates advanced cGMP manufacturing facilities and maintains a robust product development pipeline with numerous Abbreviated New Drug Applications (ANDAs) filed.
Note: There is a separate entity, SciGen Ltd (founded 1988, Singapore), which is a biotechnology company focused on biosimilars and recombinant products. ScieGen Pharmaceuticals, Inc. (USA) is primarily focused on generic small-molecule pharmaceuticals.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Aurobindo Pharma (API supply)
COMPETITION
Position:Niche Player
Competitors:Sun Pharmaceuticals, Lupin, Accord Healthcare, Teva, Amneal Pharmaceuticals
LEADERSHIP
Key Executives:
Pailla Malla Reddy - Founder
Scientific Founders:Pailla Malla Reddy
LINKS
Website:sciegenpharm.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ScieGen Pharmaceuticals, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.